Discover groundbreaking advancements in vitiligo treatment. FDA-approved ruxolitinib capsules show remarkable efficacy, with over half of adult patients experiencing significant improvement. Explore a new target, IL-33, identified by European scientists, offering potential treatment options. Chinese scientists make strides with gene therapy, a promising breakthrough in vitiligo treatment. Stay informed on the latest innovations.